Squarepoint Ops LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,766
-6.3%
34,154
+172.1%
0.00%
Q1 2023$48,831
-72.5%
12,553
-76.0%
0.00%
-100.0%
Q4 2022$177,762
-77.8%
52,283
-57.9%
0.00%
-50.0%
Q4 2021$799,000
+125.1%
124,274
+261.2%
0.00%
+100.0%
Q2 2021$355,000
-71.3%
34,409
-57.0%
0.00%
-88.9%
Q4 2020$1,239,000
-46.5%
80,053
-49.5%
0.01%
-71.0%
Q3 2020$2,314,000
+195.5%
158,523
+283.4%
0.03%
+138.5%
Q2 2020$783,000
-28.8%
41,350
-27.8%
0.01%
-53.6%
Q1 2020$1,100,000
+145.5%
57,245
+144.9%
0.03%
+833.3%
Q4 2019$448,000
+282.9%
23,378
+19.5%
0.00%
+200.0%
Q2 2019$117,000
-76.4%
19,558
-63.0%
0.00%
-83.3%
Q4 2018$495,000
-44.2%
52,817
+1.4%
0.01%
-45.5%
Q3 2018$887,000
+254.8%
52,100
+254.4%
0.01%
+266.7%
Q2 2018$250,000
+101.6%
14,700
+14.0%
0.00%
+50.0%
Q4 2017$124,000
-23.0%
12,897
-24.6%
0.00%
-71.4%
Q4 2016$161,00017,1000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders